journal article·2018-07-04

Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment

Ameeduzzafar, Syed Sarim Imam, Syed Nasir Abbas Bukhari, Asgar Ali

Publisher page

Abstract

This study was aimed to prepare, characterize and evaluate in situ gel formulations based on a blend of chitosan (CS), polyvinyl alcohol (PVA) and gellan gum (Gelrite™) for a sustained ocular delivery of besifloxacin (BSF). The developed formulations were evaluated for physicochemical properties, gelation time (Tsol-gel), rheological behaviour, antimicrobial efficacy, pharmacokinetic assessment, gamma scintigraphy study and ocular irritation. The results showed BSF sol-gel system were found to be sensitive enough which underwent instantaneous phase transition upon getting physiological stimulation. The ex vivo permeation experiments indicated that the developed formulation was able to enhance the retention of BSF at corneal surface. The HET-CAM confirmed the non-irritancy of developed formulation and also demonstrated the ability of ocular protection against strongly irritant substances. The results of gamma scintigraphy study revealed the higher concentration of drug retains at the corneal surface. In addition, optimized BSF sol-gel system showed enhanced anti-bacterial activity compared to BSF suspension.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmacy, Aljouf University, Sakaka, Saudi Arabia;

School of Pharmacy, Glocal University, Saharanpur, Uttar Pradesh, India;

Faculty of Pharmacy, Jamia Hamdard, New Delhi, India

References (34)

Show source-provided references
1. 10.1016/j.clinthera.2010.03.01310.1016/j.clinthera.2010.03.013 ↗
2. 10.1007/s12325-012-0027-710.1007/s12325-012-0027-7 ↗
3. 10.1128/AAC.00418-0910.1128/AAC.00418-09 ↗
4. Haas W · Clin Ophthalmol · 2011 · 5 · 1369
5. 10.1016/j.ajo.2011.03.01010.1016/j.ajo.2011.03.010 ↗
6. 10.1001/jamaophthalmol.2015.388810.1001/jamaophthalmol.2015.3888 ↗
7. 10.3949/ccjm.75.7.50710.3949/ccjm.75.7.507 ↗
8. 10.1016/j.jconrel.2006.05.00310.1016/j.jconrel.2006.05.003 ↗
9. 10.1016/S0378-5173(01)00760-810.1016/S0378-5173(01)00760-8 ↗
10. 10.1111/j.2042-7158.1996.tb03977.x10.1111/j.2042-7158.1996.tb03977.x ↗
11. 10.1016/j.ejpb.2011.05.00610.1016/j.ejpb.2011.05.006 ↗
12. 10.4103/2230-973X.10004210.4103/2230-973X.100042 ↗
13. 10.4103/0250-474X.10023410.4103/0250-474X.100234 ↗
14. 10.1208/pt07036710.1208/pt070367 ↗
15. 10.1517/17425247.2012.66536710.1517/17425247.2012.665367 ↗
16. 10.1089/jop.2016.008410.1089/jop.2016.0084 ↗
17. 10.1016/j.jconrel.2007.05.00910.1016/j.jconrel.2007.05.009 ↗
18. 10.1016/j.carbpol.2006.06.01510.1016/j.carbpol.2006.06.015 ↗
19. Agrawal AK · Pharmazie · 2010 · 65 · 188
20. 10.1016/j.ijbiomac.2014.02.00210.1016/j.ijbiomac.2014.02.002 ↗
21. Ameeduz Z · Sci Adv Mater · 2014 · 6 · 110.1166/sam.2014.1674 ↗
22. 10.1002/jps.2039210.1002/jps.20392 ↗
23. 10.3109/10837450.2014.91080710.3109/10837450.2014.910807 ↗
24. 10.1016/j.talanta.2013.10.05110.1016/j.talanta.2013.10.051 ↗
25. INVITOX. Frame, data bank of in vitro techniques in toxicology: hen’s eg test, INVITOX Protocol 15; Ergatt/Frame; 1990.
26. 10.1016/0887-2333(94)90170-810.1016/0887-2333(94)90170-8 ↗
27. ICH Q2R1. Topic Q2 (R1): Validation of analytical procedures: text and methodology International Conference on Harmonization, Geneva, Switzerland; 2005.
28. 10.1016/j.carbpol.2016.02.05910.1016/j.carbpol.2016.02.059 ↗
29. 10.1016/S0142-9612(00)00116-210.1016/S0142-9612(00)00116-2 ↗
30. 10.1080/0271368060081385410.1080/02713680600813854 ↗
31. 10.1016/j.colsurfb.2015.02.00710.1016/j.colsurfb.2015.02.007 ↗
32. 10.3109/1061186090350878810.3109/10611860903508788 ↗
33. 10.2174/15672011280023453010.2174/156720112800234530 ↗
34. 10.1016/j.addr.2007.08.01910.1016/j.addr.2007.08.019 ↗